Results 191 to 200 of about 359,117 (344)

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study

open access: yesEuropean Journal of Heart Failure, EarlyView.
ABSTRACT Aims In clinical practice, simplifying the number of medication titration steps while maintaining safety may improve the likelihood of patients with heart failure (HF) achieving target doses of guideline‐directed medical therapy (GDMT).
Stephen J. Greene   +8 more
wiley   +1 more source

Cardiogenic shock requiring VA‐ECMO therapy in scorpionism‐induced myocarditis

open access: yes
ESC Heart Failure, EarlyView.
Alba I. Violino   +5 more
wiley   +1 more source

Exploring safety of down‐titrating diuretics in heart failure management

open access: yesEuropean Journal of Heart Failure, EarlyView.
Event probabilities following down‐titration (), up‐titration (), or no dose change (=). One person represents approximately 10% of cases. Abstract Aims Loop diuretics are widely used in heart failure (HF) for symptom relief. Guidelines advise treating patients with the lowest possible dose of loop diuretics to maintain euvolaemia, based on expert ...
Chrit B.G. Geraeds   +5 more
wiley   +1 more source

Cardiac resynchronization therapy for enabling guideline‐directed medical therapy optimization in heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the
Daniela Tomasoni   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy